Kath Wright
Overview
Explore the profile of Kath Wright including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1416
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shemilt I, Arno A, Thomas J, Lorenc T, Khouja C, Raine G, et al.
Wellcome Open Res
. 2024 Apr;
6:210.
PMID: 38686019
Background: Identifying new, eligible studies for integration into living systematic reviews and maps usually relies on conventional Boolean updating searches of multiple databases and manual processing of the updated results....
2.
Khouja C, Brunton G, Richardson M, Stokes G, Blanchard L, Burchett H, et al.
Syst Rev
. 2022 Oct;
11(1):232.
PMID: 36303235
Background: This systematic overview was commissioned by England's Department of Health and Social Care (DHSC) to assess the evidence on direct (previously 'novel') oral anticoagulants (OACs), compared with usual care,...
3.
Corbett M, Ramessur R, Marshall D, Acencio M, Ostaszewski M, Barbosa I, et al.
Br J Dermatol
. 2022 May;
187(4):494-506.
PMID: 35606928
Background: Responses to the systemic treatments commonly used to treat psoriasis vary. Biomarkers that accurately predict effectiveness and safety would enable targeted treatment selection, improved patient outcomes and more cost-effective...
4.
Ramessur R, Corbett M, Marshall D, Acencio M, Barbosa I, Dand N, et al.
Br J Dermatol
. 2022 Apr;
187(4):481-493.
PMID: 35482474
Background: Identification of those at risk of more severe psoriasis and/or associated morbidities offers opportunity for early intervention, reduced disease burden and more cost-effective healthcare. Prognostic biomarkers of disease progression...
5.
Boehnke J, Rana R, Kirkham J, Rose L, Agarwal G, Barbui C, et al.
BMJ Open
. 2022 Feb;
12(2):e051810.
PMID: 35172996
Introduction: 'Multimorbidity' describes the presence of two or more long-term conditions, which can include communicable, non-communicable diseases, and mental disorders. The rising global burden from multimorbidity is well documented, but...
6.
Claxton L, Simmonds M, Beresford L, Cubbon R, Dayer M, Gottlieb S, et al.
Health Technol Assess
. 2022 Jan;
26(4):1-128.
PMID: 35076012
Background: Chronic heart failure is a debilitating condition that accounts for an annual NHS spend of £2.3B. Low levels of endogenous coenzyme Q10 may exacerbate chronic heart failure. Coenzyme Q10...
7.
Murphy P, Glynn D, Dias S, Hodgson R, Claxton L, Beresford L, et al.
Health Technol Assess
. 2022 Jan;
25(76):1-228.
PMID: 34990339
Background: The first histology-independent marketing authorisation in Europe was granted in 2019. This was the first time that a cancer treatment was approved based on a common biomarker rather than...
8.
Cost Effectiveness of Digital Interventions for Generalised Anxiety Disorder: A Model-Based Analysis
Jankovic D, Goncalves P, Gega L, Marshall D, Wright K, Hafidh M, et al.
Pharmacoecon Open
. 2021 Dec;
6(3):377-388.
PMID: 34961911
Background: Digital interventions (DIs) are increasingly being used in mental health care, despite limited evidence regarding their value for money. This study aimed to evaluate the cost effectiveness of DIs...
9.
South E, Rodgers M, Wright K, Whitehead M, Sowden A
Prev Med
. 2021 Dec;
154:106916.
PMID: 34922995
High prevalence of risk behaviours may exacerbate existing poor health in disadvantaged groups. We aimed to identify and bring together systematic reviews with a focus on reducing risk behaviours in...
10.
Duarte A, Llewellyn A, Walker R, Schmitt L, Wright K, Walker S, et al.
Health Technol Assess
. 2021 Sep;
25(56):1-230.
PMID: 34588097
Background: QAngio XA 3D/QFR (three-dimensional/quantitative flow ratio) imaging software (Medis Medical Imaging Systems BV, Leiden, the Netherlands) and CAAS vFFR (vessel fractional flow reserve) imaging software (Pie Medical Imaging BV,...